HIGHLIGHTS
- who: Wen Li and collaborators from the Italy Central South University, China have published the research: Effect of depression disorder on the efficacy and quality of life of first-line chemotherapy combined with immunotherapy in oncogene-driver negative NSCLC patients, in the Journal: (JOURNAL)
- what: The authors attempt to survey depression disorder and quality of life in 67 NSCLC patients with negative oncogene-driver who received chemotherapy combined with immunotherapy, and expound whether the depression disorder affected quality of life in negative oncogene-driver NSCLC survivors following chemotherapy combined with immunotherapy.
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.